ERIN WOOD: Open Payments
NPI 1730610742 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 76 payments from 19 companies in 2025. Trend: 2023 $1,024 · 2024 $1,554 · 2025 $1,753
Food & beverage: $1,393Education: $210Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $466 |
| JAZZ PHARMACEUTICALS INC. | 7 | $321 |
| AstraZeneca Pharmaceuticals LP | 8 | $171 |
| GlaxoSmithKline, LLC. | 22 | $148 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Inspire Medical Systems, Inc. | 5 | $93 |
| Insmed, Inc. | 4 | $69 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $69 |
| United Therapeutics Corporation | 2 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
Products named: DUPIXENT, XYWAV, NUCALA, TEZSPIRE, INSPIRE, Arikayce, LUMRYZ, BREZTRI.
Industry payments across PA — which companies pay providers there.
